FREENOME
Freenome is a biotech company developing accurate, accessible, and non-invasive disease screening products for proactively treating cancer and other diseases at their most manageable stages. The company is developing a simple blood test to detect early-stage cancer and make treatments more effective and provides a platform that helps design healthy conditions for an individual based on his/her cell-free genome. The company aims to reinvent disease management through systematized early detection and intervention. Charles Roberts, Gabriel Otte, Riley Ennis, and Michael Otte launched the company in 2014 in South San Francisco, California.
FREENOME
Industry:
Biotechnology Health Care Health Diagnostics Personal Health
Founded:
2014-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.freenome.com
Total Employee:
251+
Status:
Active
Total Funding:
1.1 B USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome Domain Not Resolving
Similar Organizations
BioFluidica
BioFluidica is a biotechnology company that has developed a diagnostic platform.
Lucira Health
Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Vera Therapeutics
Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.
Current Advisors List
Board_member
Board_observer
2016-01-01
Board_member
2017-01-01
Board_member
Board_member
Board_member
Board_member
2019-07-01
Board_observer
2019-07-01
Current Employees Featured
Riley Ennis Co-Founder and COO @ Freenome
Co-Founder and COO
2014-01-01
Girish Putcha Chief Medical Officer @ Freenome
Chief Medical Officer
2016-07-01
Michael Shields Staff Engineer @ Freenome
Staff Engineer
2019-07-01
Charles Roberts Co-Founder, Chief Growth Officer @ Freenome
Co-Founder, Chief Growth Officer
2015-01-01
Allan Ng VP Marketing @ Freenome
VP Marketing
2020-12-01
William Quirk CFO @ Freenome
CFO
George Morris Vice President, Engineering @ Freenome
Vice President, Engineering
2019-09-01
Adam Drake Computational Biologist @ Freenome
Computational Biologist
2015-12-01
Fabian Baier Senior Software Engineer @ Freenome
Senior Software Engineer
2020-01-01
Mike Nolan Chief Business Officer @ Freenome
Chief Business Officer
2019-05-01
Founder
Investors List
Roche
Roche investment in Corporate Round - Freenome
Polaris Partners
Polaris Partners investment in Series D - Freenome
Pura Vida Investments
Pura Vida Investments investment in Series D - Freenome
Kaiser Permanente
Kaiser Permanente investment in Series D - Freenome
Andreessen Horowitz
Andreessen Horowitz investment in Series D - Freenome
RA Capital Management
RA Capital Management investment in Series D - Freenome
Artis Ventures (AV)
Artis Ventures (AV) investment in Series D - Freenome
Eventide
Eventide investment in Series D - Freenome
Bain Capital Life Sciences
Bain Capital Life Sciences investment in Series D - Freenome
Logos Capital
Logos Capital investment in Series D - Freenome
Newest Events participated
Official Site Inspections
http://www.freenome.com Semrush global rank: 1.19 M Semrush visits lastest month: 25.91 K
- Host name: 23.185.0.2
- IP address: 23.185.0.2
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Freenome"
Our Company | Learn About Freenome's Team
Freenome is led by an experienced management team and backed by exemplary institutional and strategic investors with substantial oncology, diagnostics, and operational expertise.See details»
Freenome - Crunchbase Company Profile & Funding
Freenome is a biotech company developing accurate, accessible, and non-invasive disease screening products for proactively treating cancer and other diseases at their most manageable stages. The company is developing a …See details»
Freenome Announces CEO Transition - Freenome
Sep 25, 2024 SOUTH SAN FRANCISCO, CA (September 25, 2024) — Freenome today announced that Mike Nolan has resigned from his position as chief executive officer (CEO) for …See details»
Freenome Announces CEO Transition - PR Newswire
Sep 25, 2024 The board will be selecting a successor to guide the organization toward commercialization and increasing its public presence as Freenome focuses on bringing blood-based screening to patients ...See details»
Freenome: Contact Details, Revenue, Funding, Employees and …
Nov 12, 2024 Freenome is a California-based biotech company developing blood tests for early cancer detection, aiming to make screening accessible to everyone. The company focuses on …See details»
Freenome Company Profile 2025: Valuation, Funding
Freenome General Information Description. Developer of a multi-omics platform designed to detect cancer at an early stage through a routine blood draw. The company's platform uses a proprietary algorithm method that aims to reinvent …See details»
Freenome
Address: 279 East Grand Avenue, 5th Floor, San Francisco, CA, 94080, United States Phone: +1 (844) 625 0976 Email CompanySee details»
Freenome Announces CEO Transition - BioSpace
5 days ago The board will be selecting a successor to guide the organization toward commercialization and increasing its public presence as Freenome focuses on bringing blood …See details»
Freenome - GitHub
Freenome is a high-growth biotech company developing next-generation blood tests to detect cancer in its earliest, most treatable stages. - Freenome ... We've verified that the organization freenome controls the domain: …See details»
Freenome Announces CEO Transition - Yahoo Finance
Sep 25, 2024 Freenome is a biotechnology company pioneering an early cancer detection platform. (PRNewsfoto/Freenome Holdings, Inc.) The board will be selecting a successor to …See details»
Freenome - LinkedIn
Freenome | 33,497 followers on LinkedIn. Outpacing cancer starts with early detection | Freenome is a high-growth biotech company on a mission since 2014 to create tools that …See details»
Freenome - Company Profile - Tracxn
Dec 30, 2024 Freenome - Provider of a deep learning platform for detecting circulating cancer-related markers. Raised a total funding of $1.35B over 8 rounds from 64 investors. Founded …See details»
Freenome Company Profile - Office Locations, Competitors ... - Craft
Freenome has 5 employees at their 1 location and $507.55 m in total funding,. See insights on Freenome including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Freenome - Leadership Team - The Org
The Leadership Team at Freenome is responsible for guiding the company's strategic vision and operational execution to advance its mission of cancer detection and prevention. Comprising …See details»
Freenome - Golden
Freenome is a San Francisco-based company which uses genetic analysis for early cancer detection and risk assessment. Overview Structured Data Issues Contributors Activity. …See details»
Freenome Careers | View Current Job Opportunities
At Freenome, we pride ourselves on our team collaboration across clinical, scientific, and business specialties, as our commitment to our core values drives us to reach our fullest …See details»
Freenome - Funding, Financials, Valuation & Investors - Crunchbase
Freenome is funded by 54 investors. BrightEdge Fund and T. Rowe Price are the most recent investors. Freenome has a post-money valuation in the range of $1B to $10B as of Feb 15, …See details»
Freenome - Contacts, Employees, Board Members, Advisors
Organization. Freenome . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... Freenome has 13 current employee …See details»
Freenome Raises $254M for Multiomic-Based Early Cancer Detection
Feb 16, 2024 Freenome has announced $254M of new funding, led by Roche but with multiple other firms participating, to advance the company’s pipeline of single- and multiple-cancer …See details»
Freenome - Aiorb
What is Freenome? Freenome is a revolutionary AI platform that specializes in analyzing blood samples for the early detection of cancer and other diseases. The platform uses advanced …See details»